RITUXAN and AVASTIN do not infringe Sanofi’s CMV enhancer patents
The Court of Appeals for the Federal Circuit recently upheld a summary judgement decision that neither rituximab nor trastuzumab infringes two Sanofi... Read More
Roche teams up with Emcure for Indian oncology mAbs
According to the Ecomonic Times, Roche has teames up with Indian manufacturer Emcure Pharmaceuticals to produce rituximab and trastuzumab for the Indian... Read More